Please wait...

Maximize the utility of
imaging biomarkers
to the benefit of
patients with arthritis.
Learn more about the project  

AutoPiX is a major international project focused on improving healthcare for people with rheumatic and musculoskeletal diseases (RMDs).

The AutoPiX project brings together pharmaceutical and medical technology partners with leading academic institutions to enhance the use of imaging biomarkers for patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA), collectively known as systemic arthritides.

It aims to develop advanced imaging tools and artificial intelligence (AI) models to better diagnose, monitor, and treat these conditions. These tools will make use of imaging biomarkers—like X-rays, ultrasounds, and MRIs—to provide more precise and personalised care.

AutoPiX is a major international project focused on improving healthcare for people with rheumatic and musculoskeletal diseases (RMDs).

The AutoPiX project brings together pharmaceutical and medical technology partners with leading academic institutions to enhance the use of imaging biomarkers for patients with rheumatoid arthritis (RA), psoriatic arthritis (PsA), and axial spondyloarthritis (axSpA), collectively known as systemic arthritides.

It aims to develop advanced imaging tools and artificial intelligence (AI) models to better diagnose, monitor, and treat these conditions. These tools will make use of imaging biomarkers—like X-rays, ultrasounds, and MRIs—to provide more precise and personalised care.

Learn more about the project  
Start date
01/11/2024
Contributions
EU funding
10.729.428€
Contributing partners
4.514.408€
Industry contribution
6.423.340€
Type of action
RIA (Research and Innovation Action)
Grant agreement number
101194766
Call
IHI - Call 7
End date
31/10/2029

Project partners

Logo of Innovative health initiative

The Innovative Health Initiative from the EU Commission (IHI) is a partnership for health research and innovation between the EU and Europe's life science industries.

IHI has a total budget of €2.4 billion and is expected to have impacts on the research and innovation ecosystem; on patients and health systems; and on Europe’s competitiveness.

The Strategic Research and Innovation Agenda (SRIA) details the areas IHI should work on and helps to guide IHI’s decisions on which ideas should be turned into call topics.

Learn more about our partners  

News

15/June/2026
News update
Press Release: AutoPiX Project Celebrates European Patent Grant to Singularity Biomed for its AI Thermal-Imaging Technology
Read more  
See all news  
There have been so many advances in AI models, it would be unethical not to leverage on them for the benefit of patients.
The project is a framework to grow.
We aim to impact all patient trajectory steps – from at-risk monitoring to therapeutic monitoring.
The radiologist produces a narrative interpretation of the imaging; AI may produce a narrative as well as a quantitative interpretation that can be translated into probabilities.
In AutoPiX, we will make good use of AI.
We will change not only how the patient feels but also what the patient sees.
Why we said yes to AutoPiX? Easy: it will respond to unmet needs, is actionable, and is based on collaboration.

Catch up on the knowledge you need to understand AutoPiX's scope and results.

Take a look at the resources we have prepared to help you become an expert in AI and imaging in rheumatology.

See all resources